Fluarix Tetra Vaccine
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Fluarix Tetra Vaccine is a quadrivalent inactivated influenza vaccine. Its labelling describes it as containing inactivated (killed) influenza virus components covering four strains, given to help the body develop immunity against seasonal flu. It is described as not treating an existing influenza infection, and is given by a healthcare professional, usually once a year before the influenza season.
Product Information
The following description reflects information associated with the quadrivalent inactivated influenza vaccine and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the prevention of influenza (flu) caused by the four virus strains contained in the vaccine
- Described as suitable for children over 6 months of age and for adults
- Described as particularly important for elderly people and those with chronic conditions such as diabetes, heart failure, or kidney failure
- Described as not treating an existing influenza infection, and as not effective against avian influenza or the common cold
Described Dosage & Administration
- Administered by a healthcare professional as an injection — not self-administered
- Described as given just before the influenza season, when the virus is most active
- Described as one injection per year, with annual re-vaccination advised by the doctor based on health and immunity
Described Side Effects
Commonly described side effects include:
- Headache
- Muscle pain and joint pain
- Weakness and tiredness
- Swelling at the injection site
These are described as mild and short-lived. Like other vaccines it is described as not giving complete protection, but as reducing the severity of flu symptoms. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- The doctor should be told about any allergy to vaccines
- The doctor should be told about all other medicines being taken, as they may alter the response to the vaccine
- It is described as not effective against avian (bird) flu or the common cold
- Any persistent or severe side effect should be reviewed by a clinician
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it is a quadrivalent inactivated influenza vaccine used to help prevent seasonal flu caused by the four virus strains it contains, for children over 6 months of age and adults. It is described as not treating an existing infection. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling states it is administered by a healthcare professional as an injection, usually once a year just before the influenza season, with annual re-vaccination advised by the doctor.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.